Strata Critical Medical, Inc. (SRTA)

NCM – Real Time Price. Currency in USD

5.47

-0.19 (-3.36%)

At close: May 12, 2026, 4:00 PM EDT

5.50

+0.03 (0.55%)

After-hours: May 12, 2026, 6:35 PM EDT

07.05.2026

Strata Critical Medical Announces Expiration of Warrants

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), announced that its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Private Placement Warrants, expired in accordance with their original terms at 5:00 p.m. Eastern Time today May 7, 2026.

06.05.2026

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

06.05.2026

Strata Critical Medical Announces First Quarter 2026 Results

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the first quarter ended March 31, 2026. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Passenger business have been reclassified as discontinued operations in all periods.

20.04.2026

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens.

09.04.2026

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available at the link here.

18.03.2026

Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

Strata Critical Medical is rated 'Buy' with a 12–24 month horizon, targeting 30–35% upside as valuation remains attractive despite a recent rally. SRTA's transformation into a pure-play medical logistics provider, robust FY25 results, and margin expansion underpin confidence in forward guidance. Industry tailwinds, regulatory catalysts, and an aggressive acquisition strategy position SRTA for sustained revenue and EBITDA growth, with FY26 guidance implying an 11.6% EBITDA margin.

03.03.2026

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Videos

No Data

There is no data to display

Strata Critical Medical Announces Fourth Quarter 2025 Results

Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic growth Full year 2025 net loss from continuing operations was $20.1 million Full year 2025 revenue and Adjusted EBITDA (1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance range Raising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $33 million (2) NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the fourth quarter ended December 31, 2025. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only.

05.02.2026

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced that the Company has entered into a credit agreement with JPMorgan Chase Bank, N.A. for secured, asset-based revolving credit loans in aggregate principal amount of up to $30.0 million, which, subject to certain conditions, may be increased up to an aggregate of $50.0 million (the “ABL Facility”).

Strata Critical Medical, Inc. (SRTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Videos

No Data

Press releases

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Announces Fourth Quarter 2025 Results

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Videos

No Data

Press releases

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Announces Fourth Quarter 2025 Results

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

Search stocks

Strata Critical Medical, Inc. (SRTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Videos

No Data

Press releases

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Announces Fourth Quarter 2025 Results

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Videos

No Data

Press releases

Strata Critical Medical Announces Expiration of Warrants

Strata Critical Medical Announces First Quarter 2026 Results

Strata Critical Medical Announces Fourth Quarter 2025 Results

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution